NYSEAMERICAN : APUS

Apimeds Pharmaceuticals US, Inc.

Healthcare · Drug Manufacturers - Specialty & Generic · United Arab Emirates

Last price 3.1 USD (Oct 30, 2026, 9:31 AM EDT) · Market cap 4.68M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Apimeds Pharmaceuticals US, Inc. provides digital asset treasury solutions in bitcoin treasury infrastructure. The company was incorporated in 2020 and is based in Matawan, New Jersey. Apimeds Pharmaceuticals US, Inc. operates as a subsidiary of Inscobee., Inc.